LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Keros Therapeutics (NASDAQ: KROS)

Follow NASDAQ:KROS Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
06/20/2025
Sell
$60.00
100
$6K
4.39M
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
06/20/2025
Sell
$70.00
1,400
$98K
4.39M
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
06/20/2025
Sell
$70.00
200
$14K
743,358
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
06/20/2025
Sell
$70.00
2
$140
0
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
06/20/2025
Sell
$60.00
1
$60
0
NASDAQ KROS Keros Therapeutics
ADAR1 Capital Management, LLC / 10 percent owner
05/16/2025
Sell
$10.00
178
$2K
0
NASDAQ KROS Keros Therapeutics
Knowles Julius / director
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
GORDON CARL L / director
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
Farzan Nima / director
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
Kariv Tomer / director, 10 percent owner:
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
Nussbaum Ran / director, 10 percent owner:
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
Seth Alpna / director
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
GRAY MARY ANN / director
06/04/2025
Buy
$14.82
10,500
$156K
10,500
NASDAQ KROS Keros Therapeutics
BIENAIME JEAN JACQUES / director
06/04/2025
Buy
$14.82
10,500
$156K
10,500

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous